Anne B Warwick


Colonel, Army

Department of Primary Appointment:
School of Medicine
Director, Pediatric Sub-specialty Fellowships
Location: Uniformed Services University of the Health Sciences, Bethesda, MD
Research Interests:
Care of children, adolescents, and young adults with cancer or blood disorders
Education and professional development


A.B. - Bryn Mawr College
M.S. - University of Minnesota Graduate School
M.D. - University of Minnesota Medical School
M.P.H. - Medical College of Wisconsin
M.S.S. - U.S. Army War College

Internship - University of Minnesota Hospitals and Clinics
Residency (Pediatrics) - University of Minnesota Hospitals and Clinics
Fellowship (Pediatric Hematology, Oncology, and Bone Marrow Transplantation) - University of Minnesota Hospitals and Clinics

Medical College of Wisconsin Docere Medical Education Progam


COL (Dr.) Anne Warwick graduated from Bryn Mawr College with a degree in Latin Literature. After obtaining a Master of Science degree in Physiology she received her Doctorate in Medicine and completed a residency in Pediatrics and a fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation – all from the University of Minnesota. Later, she earned a Master of Public Health from the Medical College of Wisconsin and a Master of Strategic Studies at the U.S. Army War College, with a thesis proposing arguments for a joint medical command. She is board certified in both Pediatrics and Pediatric Hematology-Oncology.

COL Warwick’s career combines military and civilian academic medicine. Following graduation from medical school, Dr. Warwick received a direct commission as Captain in the U.S. Army Reserve. She served in the 5501st U.S. Army Hospital (Minnesota), the 114th Combat Support Hospital (Minnesota), the 4221st U.S. Army Hospital (Wisconsin), and was Division Surgeon for the 84th Division (Institutional Training), before being assigned as an Individual Mobilization Augmentee to the Department of Pediatrics at the Uniformed Services University of the Health Sciences. She was mobilized in support of Operations Desert Storm, Noble Eagle, and Enduring Freedom. She was promoted to the rank of Colonel in July 2003. In 2010, to pursue a passion for medical education, she left civilian life and was appointed into the Regular Army of the United States and assigned to the Uniformed Services University of the Health Sciences, where she is an Associate Professor of Pediatrics and Program Director of the Pediatric Hematology-Oncology Fellowship. She also holds the “A” Proficiency Designator from the Army Medical Department.

As clinician, educator and researcher, before joining the staff at what is now the Walter Reed National Military Medical Center (WRNMMC), COL Warwick practiced and taught pediatric hematology-oncology, first at Boston’s Floating Hospital for Infants and Children (Tufts University) and then at Children’s Hospital of Wisconsin (Medical College of Wisconsin), where she worked to establish multi-disciplinary clinics for survivors of childhood cancer and for children, adolescents, and young adults with bone and muscle cancers. She has served on committees for the American Society of Clinical Oncology (Education and CME) and the American Society of Pediatric Hematology and Oncology (Publications and Practice). She is currently the Principal Investigator of the Uniformed Services Oncology Consortium (including WRNMMC) for the Children’s Oncology Group.

Representative publications, projects, and/or deployments

U.S. Army "A" Designator

Director, Pediatric Subspecialty Fellowships

Program Director, Pediatric Hematology-Oncology Fellowship

Director, Division of Hematology and Oncology

American Academy of Pediatrics, Section on Hematology & Oncology, Executive Committee

American Society of Clinical Oncology, Education Committee

Pediatric Milestones 2.0 working group, Accreditation Council for Graduate Medical Education

Principal Investigator, Uniformed Services Oncology Consortium, Children's Oncology Group

Children's Oncology Group member; actively involved in the following committees: renal tumors, bone tumors, liver and rare tumors.

Secretary-Treasurer, USUHS Faculty Senate


Survival and late effects after allogeneic hematopoietic cell transplantation for hematologic malignancy at less than three years of age. Biol Blood Marrow Transplant. PMID: 28461213

Defining medical professionalism across the years of training and experience at the Uniformed Services University of the Health Sciences. Military Medicine 181(10):1294-1299, 2016. PMID:27753566

Allopurinol use during maintenance therapy for Acute Lymphoblastic Leukemia avoids Mercaptopurine-related hepatotoxicity. J Pediatr Hematol Oncol 38(2):147-51, 2016. PMID:26808368

Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamics, and safety assessments. Pediatr Blood Cancer 61:238-44, 2014. Epub 2013 Aug 31. PMID:23997016

Phase 2 Trial of Pemetrexed in children with refractory solid tumors: a Children's Oncology Group Study. Pediatr Blood Cancer 60:237-241, 2013. Epub 2012 Jun 28. PMID:22745043

Management of adults with Wilms tumor: recommendations based on international consensus. Expert Rev Anticancer Ther 11:1105-13, 2011. PMID:21806333

Pregnancy after hematopoietic-cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 19:157-66, 2011. Epub 2010 Jul 24. PMID:20659574

Late effects in adult survivors of childhood cancer: considerations for the general practitioner. WMJ 109:98-107, 2010. PMID:20443329

Portal hypertension in children with Wilms tumor; a report from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys 77:210-6, 2010. Epub 2009 Aug 19. PMID:19695791

Outcomes following mechanical ventilation in children undergoing bone marrow transplantation. Bone Marrow Transplant 22:787-94, 1998. PMID:9827977